CORT

Corcept Therapeutics Incorporated - Common Stock (CORT)

About Corcept Therapeutics Incorporated - Common Stock (CORT)

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Details

Daily high

$117.90

Daily low

$108.41

Price at open

52 Week High

$126.38

52 Week Low

$28.66

Market cap

11.9B

Dividend yield

Volume

1,106

Avg. volume

1.8M

P/E ratio

263.41

Corcept Therapeutics Incorporated - Common Stock News